User:Mr. Ibrahem/Lanreotide

Lanreotide, sold under the brand name Somatuline, is a medication used to treat acromegaly, neuroendocrine tumors such as carcinoid, and thyroid tumors. In acromegaly it is used when other treatments are not effective. It is given by injection under the skin or into a muscle.

Common side effects include diarrhea, abdominal pain, nausea, gallstones, joint pain, and pain at the site of injection. Other side effects may include pancreatitis, high blood sugar, low blood sugar, and liver problems. It is a somatostatin analogue and works by decreasing levels of growth hormone, insulin, and glucagon.

Lanreotide was approved for medical use in the United States in 2007. In the United Kingdom it costs the NHS about £550 at a dose of 60 mg per month as of 2021. This amount in the United States costs about 6,100 USD.